Search Results - "BOSCHELLI, Frank"
-
1
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants
Published in Journal of clinical oncology (20-01-2009)Get full text
Journal Article -
2
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
Published in Molecular cancer therapeutics (01-05-2008)“…Src family kinase activity is elevated in many human tumors, including breast cancer, and is often associated with aggressive disease. We examined the effects…”
Get full text
Journal Article -
3
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells
Published in Cancer research (Chicago, Ill.) (01-12-2006)“…Resistance to imatinib represents an important scientific and clinical issue in chronic myelogenous leukemia. In the present study, the effects of the novel…”
Get full text
Journal Article -
4
SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis
Published in Molecular cancer therapeutics (01-05-2010)“…In the current study, we have examined the efficacy of a Src/Abl kinase inhibitor SKI-606 (Bosutinib) for its effect on prostate cancer growth and skeletal…”
Get full text
Journal Article -
5
Discovery of Benzisoxazoles as Potent Inhibitors of Chaperone Heat Shock Protein 90
Published in Journal of medicinal chemistry (14-02-2008)“…Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signaling proteins and is a promising target in tumor biology…”
Get full text
Journal Article -
6
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts
Published in Molecular cancer therapeutics (01-06-2009)“…Recently, Src tyrosine kinase has emerged as an attractive target for anticancer therapy, and Src is overexpressed in pancreatic cancer. The purpose of the…”
Get full text
Journal Article -
7
Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia
Published in The Journal of pharmacology and experimental therapeutics (01-12-2009)“…Src kinase signaling has been implicated in multiple mechanisms of ischemic injury, including vascular endothelial growth factor (VEGF)-mediated vascular…”
Get more information
Journal Article -
8
Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase Activity
Published in Journal of medicinal chemistry (08-11-2001)“…Subsequent to the discovery of 4-[(2,4-dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile (1a) as an inhibitor of Src kinase activity (IC50 = 30 nM),…”
Get full text
Journal Article -
9
Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT)
Published in Leukemia research (01-06-2008)“…Abstract We investigated the role of Src family kinases (SFKs) in the regulation of STAT activation in myeloid leukemia cells. Two of 6 AML cell lines…”
Get full text
Journal Article -
10
Synthesis and Src Kinase Inhibitory Activity of a Series of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles
Published in Journal of medicinal chemistry (28-12-2006)“…Compound 1 (SKI-606, bosutinib), a 7-alkoxy-4-[(2,4-dichloro-5-methoxyphenyl)amino]-3-quinolinecarbonitrile, is a potent inhibitor of Src kinase activity. We…”
Get full text
Journal Article -
11
Identification of a Conserved Sequence Motif That Promotes Cdc37 and Cyclin D1 Binding to Cdk4
Published in The Journal of biological chemistry (26-03-2004)“…Cdc37 is a molecular chaperone that is important for the stability and activity of several protein kinases, including Cdk4 and Raf1. We first determined, using…”
Get full text
Journal Article -
12
Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles
Published in Journal of medicinal chemistry (01-03-2001)“…Screening of a directed compound library in a yeast-based assay identified 4-[(2,4-dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile (2a) as a Src…”
Get full text
Journal Article -
13
Bosutinib: A review of preclinical studies in chronic myelogenous leukaemia
Published in European journal of cancer (1990) (01-07-2010)“…Abstract Bosutinib (SKI-606) is an orally active Src and Abl kinase inhibitor presently in Phase III trials for treatment of chronic myelogenous leukaemia…”
Get full text
Journal Article -
14
A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo
Published in Cancer research (Chicago, Ill.) (15-02-2007)“…The central role of Src in the development of several malignancies, including breast cancer, and the accumulating evidence of its interaction with receptor…”
Get full text
Journal Article -
15
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib
Published in Journal of hematology and oncology (07-07-2015)“…Bosutinib is a recently approved ABL inhibitor. In spite of the well-documented effectiveness of BCR-ABL inhibitors in treating chronic myeloid leukemia,…”
Get full text
Journal Article -
16
SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice
Published in Cancer research (Chicago, Ill.) (15-01-2003)“…Constitutive tyrosine kinase activity of Bcr-Abl promotes proliferation and survival of chronic myelogenous leukemia (CML) cells. Inhibition of Bcr-Abl…”
Get full text
Journal Article -
17
SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models
Published in Cancer research (Chicago, Ill.) (15-06-2005)“…Src up-regulation is a common event in human cancers. In colorectal cancer, increased Src levels are an indicator of poor prognosis, and progression to…”
Get full text
Journal Article -
18
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells
Published in International journal of cancer (15-04-2009)“…Unbalanced histone deacetylase (HDAC) hyperactivity is a common feature of tumor cells. Inhibition of HDAC activity is often associated with cancer cell growth…”
Get full text
Journal Article -
19
Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment
Published in Bioorganic & medicinal chemistry letters (15-06-2008)“…The strategies, synthesis, and SAR behind novel isoquinolinedione IGFR inhibitors ( 1) are reported. Insulin-like growth factor receptor (IGF-1R) is a growth…”
Get full text
Journal Article -
20
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model
Published in Bioorganic & medicinal chemistry letters (01-08-2011)“…An extension of our previously reported series of macrocyclic ortho-aminobenzamide Hsp90 inhibitors is reported. Addition of a second methyl group to the…”
Get full text
Journal Article